English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A quasi experimental study was conducted on outcomes of Induction Chemotherapy for advanced head and neck cancer patients from October 2015 to September 2016 at Faridpur Medical College Hospital, Faridpur. A total of 40 patients with Stages T3/T4, N0-N3, M0 and histological proved Squamous cell carcinoma of the head & neck (SCCHN) were selected to receive three cycles of chemotherapy prior to loco-regional primary concurrent chemoradiotherapy (CCRT). The induction chemotherapy regimen was a combination of Inj. paclitaxel and Inj cisplatin. The primary end point of study was clinical outcome of the patients. The response rate to induction chemotherapy was 55% for the primary tumor (CR: 12% and PR: 43%). Complete disappearance of the primary tumor occurred more often than that of the lymph node metastases. The response rate to induction chemotherapy for lymph node metastases was 24% (CR: 10% and PR: 14 %). Faridpur Med. Coll. J. Jul 2016;11(2): 54-57

Induction Chemotherapy for Advanced Head and Neck Cancer Patients: Outcomes of A Quasi-Experimental Study.